|
|
||||||||||||||
|
|
|||||||||||||||
PAPER |
Johns Hopkins School of Medicine, Department of Radiology, Division of Nuclear Medicine, Baltimore, USA
Correspondence to:
Correspondence to:
Dr B Chin, Duke University School of Medicine, PO Box 3949, Duke University Medical Center, Durham, NC 27710;
chin0004{at}mc.duke.edu
Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.
Keywords: positron emission tomography; 18F-Fluoro-2-deoxyglucose
Abbreviations: PET, positron emission tomography; FDG, 18F-fluoro-2-deoxyglucose; CT, computed tomography; CEA, carcinoembryonic antigen
This article has been cited by other articles:
![]() |
J. M. Farma, A. A. Santillan, M. Melis, J. Walters, D. Belinc, D.-T. Chen, E. A. Eikman, and M. Malafa PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms Ann. Surg. Oncol., September 1, 2008; 15(9): 2465 - 2471. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |